Assessment Of Prognostic Factors In Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Patients (Pts) Treated With Abiraterone Acetate (Aa) After Docetaxel (Doc).

JOURNAL OF CLINICAL ONCOLOGY(2016)

引用 0|浏览16
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要